XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 93 filers reported holding XENON PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $188,712 | +63.6% | 4,840 | +80.6% | 0.00% | – |
| Q1 2024 | $115,374 | +26.5% | 2,680 | +35.4% | 0.00% | – |
| Q4 2023 | $91,198 | -89.3% | 1,980 | -95.7% | 0.00% | -100.0% |
| Q2 2021 | $851,000 | +4.0% | 45,722 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $818,000 | +16.4% | 45,722 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $703,000 | +38.9% | 45,722 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $506,000 | -11.7% | 45,722 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $573,000 | +10.6% | 45,722 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $518,000 | -13.5% | 45,722 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $599,000 | +45.4% | 45,722 | 0.0% | 0.00% | – |
| Q3 2019 | $412,000 | -8.6% | 45,722 | 0.0% | 0.00% | – |
| Q2 2019 | $451,000 | +279.0% | 45,722 | +290.8% | 0.00% | – |
| Q1 2019 | $119,000 | – | 11,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,754,266 | $107,388,831 | 7.33% |
| Altium Capital Management LP | 360,600 | $14,059,794 | 5.74% |
| Affinity Asset Advisors, LLC | 994,227 | $38,764,911 | 4.47% |
| First Light Asset Management, LLC | 1,306,260 | $50,931,077 | 4.46% |
| Nan Fung Group Holdings Ltd | 106,680 | $4,159,453 | 4.44% |
| Ally Bridge Group (NY) LLC | 169,369 | $6,603,697 | 3.93% |
| TLS Advisors LLC | 32,956 | $1,285 | 3.22% |
| BRAIDWELL LP | 2,560,573 | $99,836,741 | 3.13% |
| Paradigm Biocapital Advisors LP | 2,043,280 | $79,667,487 | 3.05% |
| BRIDGER MANAGEMENT, LLC | 146,800 | $5,723,732 | 2.94% |